大洋生物
(003017)
| 流通市值：17.33亿 | | | 总市值：21.05亿 |
| 流通股本：6915.85万 | | | 总股本：8400.00万 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 353,101,246.36 | 353,991,111.37 | 315,569,749.06 | 372,261,090.55 |
| 应收票据及应收账款 | 92,449,141.35 | 61,607,249.91 | 74,153,627.53 | 70,607,193.32 |
| 其中：应收票据 | 3,401,524.55 | 2,852,457.57 | 2,967,423.68 | 53,200 |
| 应收账款 | 89,047,616.8 | 58,754,792.34 | 71,186,203.85 | 70,553,993.32 |
| 应收款项融资 | 88,901,316.75 | 65,441,439.08 | 60,917,151.86 | 58,519,299.52 |
| 预付款项 | 15,703,429.39 | 43,164,965.2 | 17,738,871.38 | 15,558,557.72 |
| 其他应收款合计 | 1,192,970.7 | 1,279,862.19 | 2,193,238.22 | 2,184,495.79 |
| 存货 | 120,182,793.46 | 119,784,613.63 | 131,329,384.49 | 143,828,348.77 |
| 其他流动资产 | 3,923,804.62 | 4,832,983.65 | 2,918,377.94 | 3,947,011.67 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 695,529,906.75 | 690,549,046.95 | 667,068,405.96 | 666,905,997.34 |
| 非流动资产: | | | | |
| 长期股权投资 | 102,618,150.25 | 100,970,777.38 | 85,812,883.33 | 71,097,866.03 |
| 其他非流动金融资产 | 20,418,654.92 | 20,418,654.92 | 19,393,052 | 19,393,052 |
| 投资性房地产 | 173,042.86 | 206,257.75 | 239,472.59 | 272,687.47 |
| 固定资产 | 514,996,538.64 | 525,947,749.13 | 524,150,839.71 | 538,026,486.59 |
| 在建工程 | 163,282,602.96 | 155,148,685.46 | 148,981,005.5 | 138,266,409.53 |
| 使用权资产 | 145,237.84 | 363,094.66 | 580,951.48 | 798,808.33 |
| 无形资产 | 90,338,213.93 | 91,064,457.46 | 91,480,972.34 | 92,122,772.63 |
| 长期待摊费用 | 2,039,959.07 | 2,104,113.59 | 117,924.54 | 128,032.35 |
| 递延所得税资产 | 29,562,096.08 | 32,311,970.27 | 39,794,835.79 | 44,080,010.15 |
| 其他非流动资产 | 35,794,388.57 | 34,464,512.4 | 34,798,674.02 | 33,595,998.89 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 959,368,885.12 | 963,000,273.02 | 945,350,611.3 | 937,782,123.97 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,654,898,791.87 | 1,653,549,319.97 | 1,612,419,017.26 | 1,604,688,121.31 |
| 流动负债: | | | | |
| 短期借款 | 314,120,470.14 | 358,056,520.01 | 338,568,451.48 | 280,919,021.36 |
| 应付票据及应付账款 | 179,065,372.31 | 158,914,160.23 | 161,109,742.62 | 176,489,026.47 |
| 其中：应付票据 | 94,335,216.4 | 51,119,316.8 | 79,491,637.09 | 82,009,836.43 |
| 应付账款 | 84,730,155.91 | 107,794,843.43 | 81,618,105.53 | 94,479,190.04 |
| 预收款项 | 11,000 | 13,394.49 | 80,550.46 | 72,549.54 |
| 合同负债 | 6,555,817.36 | 3,689,389.51 | 7,618,984.74 | 5,815,955.47 |
| 应付职工薪酬 | 11,386,230.54 | 13,885,263.72 | 13,223,049.87 | 13,158,943.22 |
| 应交税费 | 4,021,929.32 | 8,615,991.18 | 5,527,409.88 | 7,346,049.48 |
| 其他应付款合计 | 14,609,492.8 | 13,176,037.98 | 21,481,897.34 | 43,377,581.32 |
| 应付股利 | - | - | - | 36,672,750 |
| 一年内到期的非流动负债 | 9,506,584.93 | 9,506,584.93 | 438,129.43 | 438,129.43 |
| 其他流动负债 | 1,966,673.48 | 1,840,304.43 | 1,770,525.98 | 657,245.17 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 541,243,570.88 | 567,697,646.48 | 549,818,741.8 | 528,274,501.46 |
| 非流动负债: | | | | |
| 长期借款 | - | - | - | 30,024,166.67 |
| 递延收益 | 8,609,853.79 | 9,010,595.89 | 9,813,285.22 | 10,326,568.3 |
| 递延所得税负债 | 22,486,267.84 | 23,691,283.72 | 24,714,672.94 | 25,732,924.39 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 31,096,121.63 | 32,701,879.61 | 34,527,958.16 | 66,083,659.36 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 572,339,692.51 | 600,399,526.09 | 584,346,699.96 | 594,358,160.82 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 84,000,000 | 84,000,000 | 84,000,000 | 84,000,000 |
| 资本公积 | 530,468,541.13 | 528,225,562.57 | 525,064,886.65 | 539,186,413.02 |
| 减:库存股 | 21,911,422.12 | 17,930,051.12 | 27,007,104.98 | 38,712,350.87 |
| 专项储备 | 2,553,485.47 | 2,660,455.19 | 3,290,442.2 | 2,961,264.51 |
| 盈余公积 | 41,435,155.9 | 41,435,155.9 | 32,456,981.45 | 32,456,981.45 |
| 未分配利润 | 443,098,439.64 | 413,769,491.63 | 410,267,111.98 | 390,437,652.38 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,079,644,200.02 | 1,052,160,614.17 | 1,028,072,317.3 | 1,010,329,960.49 |
| 少数股东权益 | 2,914,899.34 | 989,179.71 | - | - |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,082,559,099.36 | 1,053,149,793.88 | 1,028,072,317.3 | 1,010,329,960.49 |
| 负债和股东权益合计 | 1,654,898,791.87 | 1,653,549,319.97 | 1,612,419,017.26 | 1,604,688,121.31 |
| 公告日期 | 2025-04-22 | 2025-04-22 | 2024-10-19 | 2024-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |